LearnGlossaryMarketStocksSuperinvestorsSign in

CARL

Carlsmed, Inc.

Healthcare · $384M market cap

Verdict

We can't put a fair value on CARL right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.

Business quality

1 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?
Equity per share growth—?
Sales growth91.5% a year✓
Free cash flow growth—?
Return on invested capital-40.9%✗

Follow CARL

Track it on your watchlist and see the full analysis. Free.

Create a free account

Insider activity

Since Sep 8, 2026: no open-market purchases and 1 other filing (stock awards, tax withholding and similar). Why purchases matter

Other filings

Bertolini Jeffrey

Chief Operating Officer · 2026-09-08

Award

$762K

About Carlsmed, Inc.

Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting…

Medical - Healthcare Information Services

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works